Duggan Robert W's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Dec 13, 2024
- Accession no.
- 0001437749-24-037509
- Filed
- Dec 13, 2024
- Trade date
- Dec 11, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $972.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Duggan Robert WCIK 0001055919 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | Common Stock | PPurchaseAcquired | +6,054 | $16.74F1 | +$101,343.96 | 42,178,057 | Direct | |
| Dec 11, 2024 | Common Stock | PPurchaseAcquired | +50,000 | $17.42 | +$871,000 | 42,228,057 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Volume-weighted average price.
Referenced by the price of 1 transaction in Table I.